Digital Journal
Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
The Company intends to enter in discussions with the U.S. Food and Drug Administration ("FDA") to pursue Breakthrough Therapy Designation for BMND08, a move that could accelerate ...
19 hours ago